Ons wil graag hê dat jy deel word van ons gemeenskap. Sluit aan by ons Discord om met ons en ander lede te skakel!

Ticker
QNTM

Price
35.00
Stock movement up
+4.82 (15.97%)
Company name
Quantum BioPharma Ltd.
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Markkapitalisasie
133.59M
Ondernemingswaarde
-
Prys/Verkope
-
Prys/Boek
-
Dividendopbrengs
-
Dividendgroei
-
Groei jare
-
FCF uitbetaling
-
Agterlopende P/E
-
Volgende P/E
-
PEG
-
EPS groei
-
1 jaar opbrengs
156.41%
3 jaar opbrengs
-13.60%
5 jaar opbrengs
-33.75%
10 jaar opbrengs
-
Laaste opgedateer: 2025-08-27

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDE

QNTM betaal nie dividende nie of geen data is ontvang nie

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

WAARDERING

Waarderingsverhoudings

Loading...
Waarderingsverhoudings gegewens
Agterlopende P/E-
Prys tot OCF-
Prys tot FCF-
Prys tot EBITDA-
EV tot EBITDA-

Waardering (Verkope/Boekwaarde)

Loading...
Waardering (Verkope/Boekwaarde) gegewens
Prys tot verkope-
Prys tot Boekwaarde-
EV tot verkope-

FINANSIËLE

AANDELE INLIGTING

Aandele grafiek

Loading...
Aandele prys data
Open34.88
Daaglikse hoog38.25
Daaglikse laag31.91
Daaglikse volume826K
Hoogtepunt van alle tye9080.17
1j analiseraaming169.00
Beta1.62
EPS (TTM)-
Dividend per aandeel-
Ex-dividend datum-
Volgende verdienste datum-

Afwaartse potensiaal

Loading...
Afwaartse potensiaal gegewens
QNTMS&P500
Huidige prysdaling vanaf die hoogste punt van alle tye-99.61%-3.04%
Hoogste prysdaling-99.97%-56.47%
Datum van hoogste daling27 Jan 20259 Mar 2009
Gemiddelde daling vanaf hoogtepunt-90.99%-11.04%
Gemiddelde tyd tot nuwe hoogtepunt104 days12 days
Maksimum tyd tot nuwe hoogtepunt1695 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

MAATSKAPPY BESONDERHEDE
QNTM (Quantum BioPharma Ltd.) company logo
Markkapitalisasie
133.59M
Markkapitalisasie kategorie
Small-cap
Beskrywing
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is headquartered in Toronto, Canada.
Werknemers
0
Beleggerverhoudings
-
CEO
Land
USA
Stad
Aandele tipe
-
CCC status
-
Dividendfrekwensie
-
GEBEURE EN AANBIEDINGS
GebeureAanbiedings
Loading...

iO Charts is a Seeking Alpha partner

VERSTAAN DIE BESIGHEID
Loading...